UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
__________________
FORM
8-K
__________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 29,
2008
Lexicon
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
000-30111
|
76-0474169
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
Number)
|
8800
Technology Forest Place
The
Woodlands, Texas 77381
(Address
of principal executive
offices
and Zip Code)
(281)
863-3000
(Registrant’s
telephone number,
including
area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligations of the registrant under any of the following
provisions:
□
|
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|
□
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
□
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
|
□
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers
|
(b) On
April 29, 2008, the employment of Julia P. Gregory, our executive vice president
and chief financial officer, was terminated. In such capacity, Ms.
Gregory had performed the functions of our principal financial officer and
principal accounting officer.
(c) On
April 29, 2008, James F. Tessmer assumed the functions of our principal
financial officer and principal accounting officer. Mr. Tessmer, 48,
has been our vice president, finance and accounting since November 2007 and
previously served as our senior director of finance from February 2004 to
November 2007 and director of finance from April 2001 to February
2004. Mr. Tessmer is a certified public accountant and received his
B.B.A. from the University of Wisconsin
–
Milwaukee and his
M.B.A. from the University of Houston.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Lexicon
Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
Date: April
29, 2008
|
By:
|
/s/
Jeffrey L. Wade
|
|
|
Jeffrey
L. Wade
|
|
|
Executive Vice
President
and
|
|
|
General
Counsel
|